ConductScience.org, home

Paper324671

Synergy, additivism and antagonism in immunosuppression. A critical review.

Berenbaum MC. Clin Exp Immunol, 1977. Cited by 349 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Synergy, additivism and antagonism in immunosuppression. A critical review. Papers, record 324671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/324671

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergy, additivism and antagonism in immunosuppression. A critical review.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
349
iCite
Relative citation ratio, by iCite
9.45
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berenbaum MCM C

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
Animals
Antibody Formation
Dose-Response Relationship, Drug
Drug Interactions
Drug Synergism
Drug Therapy, Combination
Humans

Source PubMed

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,315,108THE EFFECT OF DELAYED ADMINISTRATION OF FOLINIC ACID ON IMMUNOLOGICAL INHIBITION BY METHOTREXATE.Immunology1965https://conductscience.org/library/papers/14315108PubMed
214,217,927THE RELATION OF RADIATION DOSAGE TO ENHANCEMENT, DEPRESSION, AND RECOVERY OF THE INITIAL FORSSMAN HEMOLYSIN RESPONSE IN RABBITS.J Infect Dis1964https://conductscience.org/library/papers/14217927PubMed
314,189,285INDUCTION OF TOLERANCE WITH DISRUPTED ANTIGEN, IMURAN, AND SUBLETHAL IRRADIATION.Surg Forum1964https://conductscience.org/library/papers/14189285PubMed
414,158,063AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.J Lab Clin Med1964https://conductscience.org/library/papers/14158063PubMed
514,066,954ENHANCED SUPPRESSION OF THE SECONDARY IMMUNE RESPONSE BY COMBINATION OF 6-MERCAPTOPURINE DUAZOMYCIN A'.Nature1963https://conductscience.org/library/papers/14066954PubMed
613,968,137Suppression of the immune response by drugs in combination.Proc Soc Exp Biol Med1962https://conductscience.org/library/papers/13968137PubMed
813,465,303Antagonisms and antagonists.Pharmacol Rev1957https://conductscience.org/library/papers/13465303PubMed
131,099,730Enhancement of skin grafts in the mouse. The combined used of specific and nonspecific immunosuppression.Transplantation1975https://conductscience.org/library/papers/1099730PubMed
145,770,114Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine.Proc Soc Exp Biol Med1969https://conductscience.org/library/papers/5770114PubMed
154,144,500Combination chemotherapy for clinically established graft-versus-host disease in mice.Cancer Res1973https://conductscience.org/library/papers/4144500PubMed
164,380,568Quantitative studies on tissue transplantation immunity. 8. The effects of irradiation.Proc R Soc Lond B Biol Sci1966https://conductscience.org/library/papers/4380568PubMed
174,353,772Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol.J Clin Invest1973https://conductscience.org/library/papers/4353772PubMed
184,226,527Immunosuppression by pyrimidine nucleoside analogs.Biochem Pharmacol1966https://conductscience.org/library/papers/4226527PubMed
194,590,921Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse.Cancer Res1974https://conductscience.org/library/papers/4590921PubMed
204,558,906The effect of combined immunosuppressive agents and cell-free antigen on xenograft survival.Transplantation1972https://conductscience.org/library/papers/4558906PubMed
214,556,073Passive enhancement of kidney allografts: potentiation with antithymocyte serum.Transplantation1972https://conductscience.org/library/papers/4556073PubMed
224,717,916The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.Clin Exp Immunol1973https://conductscience.org/library/papers/4717916PubMed
235,031,609Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone.Arthritis Rheum1972https://conductscience.org/library/papers/5031609PubMed
245,031,608Therapeutic studies in NZB-W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination.Arthritis Rheum1972https://conductscience.org/library/papers/5031608PubMed
254,941,150Immunological enhancement.Transplant Proc1971https://conductscience.org/library/papers/4941150PubMed

See all 28 references

Cited by105

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 349 citations.

PMIDTitleJournalYearIn PapersSource
42,959,165Genomics and metabolomics analyses reveal the endophytic fungus Neocucurbitaria sp. VM-36 as a potential source of bioactive metabolites against methicillin-resistant Staphylococcus aureus.Front Microbiol2026https://conductscience.org/library/papers/42959165PubMed
41,470,047SynVerse: a modular framework for building and evaluating deep learning-based drug synergy prediction models.Brief Bioinform2025https://conductscience.org/library/papers/41470047PubMed
41,086,909Synergistic toxicity of PFAS and microplastic mixtures across five human cell lines.Environ Pollut2025https://conductscience.org/library/papers/41086909PubMed
40,857,031Prediction of mixture toxicity of essential oil constituents using nonparametric and parametric models against Musca domestica L.Pest Manag Sci2025https://conductscience.org/library/papers/40857031PubMed
39,140,776Non-small cell lung cancer sensitisation to platinum chemotherapy via new thiazole-triazole hybrids acting as dual T-type CCB/MMP-9 inhibitors.J Enzyme Inhib Med Chem2024https://conductscience.org/library/papers/39140776PubMed
38,675,443State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38675443PubMed
36,541,800Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.J Virol2023https://conductscience.org/library/papers/36541800PubMed
36,493,860Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.Exp Neurol2023https://conductscience.org/library/papers/36493860PubMed
35,972,279In Vitro Selective Combinatory Effect of Ciprofloxacin with Nitroxoline, Sanguinarine, and Zinc Pyrithione against Diarrhea-Causing and Gut Beneficial Bacteria.Microbiol Spectr2022https://conductscience.org/library/papers/35972279PubMed
35,849,634Sample-efficient identification of high-dimensional antibiotic synergy with a normalized diagonal sampling design.PLoS Comput Biol2022https://conductscience.org/library/papers/35849634PubMed
35,620,200Evaluation of synergism in drug combinations and reference models for future orientations in oncology.Curr Res Pharmacol Drug Discov2022https://conductscience.org/library/papers/35620200PubMed
35,493,962Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer.Geohealth2022https://conductscience.org/library/papers/35493962PubMed
35,327,591Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice.Biomolecules2022https://conductscience.org/library/papers/35327591PubMed
35,054,773High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.Int J Mol Sci2022https://conductscience.org/library/papers/35054773PubMed
34,764,748Modulating effects of the synergistic combination of extracts of herbal drugs on cyclophosphamide-induced immunosuppressed mice.Saudi J Biol Sci2021https://conductscience.org/library/papers/34764748PubMed
34,185,537Synergy in Nanomedicine: What It Is Not, and What It Might Be.Nano Lett2021https://conductscience.org/library/papers/34185537PubMed
34,164,422Urolithins: The Gut Based Polyphenol Metabolites of Ellagitannins in Cancer Prevention, a Review.Front Nutr2021https://conductscience.org/library/papers/34164422PubMed
32,507,997Sub-additive (antagonistic) interaction of lacosamide with lamotrigine and valproate in the maximal electroshock-induced seizure model in mice: an isobolographic analysis.Pharmacol Rep2020https://conductscience.org/library/papers/32507997PubMed
31,850,215Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening.Front Oncol2019https://conductscience.org/library/papers/31850215PubMed
31,849,651Additive Dose Response Models: Defining Synergy.Front Pharmacol2019https://conductscience.org/library/papers/31849651PubMed

See all 105 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/324671

GET https://conductscience.org/api/papers/v1/324671/references?page=2